Drug information is subject to change and may not cover all uses, directions, precautions, warnings, interactions, reactions, or adverse effects
Clinical studies, including the STEP 1 extension trial with semaglutide 2.4 mg, have shown that patients often regain a significant proportion of weight lost during GLP-1 therapy, typically over several months
The cancellation of coverage was due to the prices of weight loss drugs, ranging from $1,100 to $1,400 per month, fiscally straining the nearly insolvent SHP
The purity, stability, and consistency may vary between batches and vendors
Fatigue may develop as calorie intake decreases
INN does not endorse or recommend the business, products, services or securities of any company profiled